2026年全球連續血糖值監測市場報告

近年來，持續血糖監測市場發展迅速，預計將從2025年的94.4億美元成長到2026年的108.7億美元，複合年成長率達15.1%。過去幾年成長要素包括即時血糖監測設備供不應求、初始持續血糖監測設備高成本、糖尿病管理意識不斷提高、對指尖採血檢測的依賴以及醫院擴大採用監測解決方案。

預計未來幾年，持續血糖監測市場將快速成長，到2030年市場規模將達到188.6億美元，複合年成長率（CAGR）為14.8%。預測期內的成長要素包括植入式和穿戴式感測器技術的進步、與行動醫療和遠端醫療平台的整合、全球糖尿病患者人數的成長、非侵入性血糖監測技術的進步以及居家醫療和遠端患者監護服務的擴展。預測期內的主要趨勢包括糖尿病患者對持續血糖監測設備的日益普及、微創和植入式感測器的發展、與即時數據分析和警報系統的整合、家庭監測和遠端醫療解決方案的擴展，以及對兒童和老年人血糖監測解決方案需求的成長。

預計未來幾年，糖尿病盛行率的不斷上升將推動持續血糖監測市場的成長。糖尿病是一種慢性疾病，患者體內胰島素分泌不足或無法有效利用自身產生的胰島素，導致血糖值升高。糖尿病患者數量的增加主要是由於不健康的飲食習慣，例如高糖、高脂肪和高加工食品的攝入，這些因素會導致肥胖和胰島素功能受損。持續血糖監測透過提供血糖值水平的即時變化趨勢來輔助糖尿病管理，使患者能夠及時調整飲食、藥物和運動量，有助於改善血糖控制。例如，根據美國非營利組織美國糖尿病協會發布的數據，到2022年，美國糖尿病患者人數將達到約2,550萬人（約佔總人口的7.6%），比前一年成長3%。糖尿病患者數量的成長趨勢正在推動持續血糖監測市場的成長。

持續血糖監測市場的主要企業正致力於開發創新產品，例如基於感測器的血糖監測儀，以提高準確性、即時追蹤功能和患者便利性。基於感測器的血糖監測儀使用植入皮下的小型感測器持續測量血糖值。例如，2024年8月，美國醫療公司德康（Dexcom）推出了Stello，這是第一款專為不使用胰島素的成年人設計的非處方（OTC）持續血糖監測儀（CGM）。 Stello使用佩戴在上臂後側的小型感測器，無需處方箋或指尖採血，即可全天候將即時血糖值數據直接傳輸到智慧型手機。該設備提供個人化分析和趨勢分析，幫助患者了解飲食、運動和睡眠等因素如何影響血糖值血糖值。

目錄

第1章執行摘要

第2章 市場特徵

• 市場定義和範圍
• 市場區隔
• 主要產品和服務概述
• 全球連續血糖監測市場：吸引力評分及分析
• 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

• 供應鏈與生態系概述
• 主要原料、資源和供應商清單
• 主要經銷商和通路合作夥伴名單
• 主要最終用戶列表

第4章 全球市場趨勢與策略

• 關鍵技術和未來趨勢
  • 生物技術、基因組學和精準醫學
  • 數位化、雲端運算、巨量資料、網路安全
  • 物聯網、智慧基礎設施和互聯生態系統
  • 工業4.0和智慧製造
  • 人工智慧（AI）和自主人工智慧
• 主要趨勢
  • 持續血糖監測設備在糖尿病患者中越來越受歡迎
  • 開發微創植入式感測器
  • 即時數據分析與警報系統整合
  • 擴展家庭監測和遠端醫療解決方案
  • 兒童和老年人血糖監測解決方案的需求不斷成長

第5章 終端用戶產業市場分析

• 醫院
• 居家護理患者
• 診斷中心和診所
• 糖尿病管理計劃
• 研究和學術機構

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

• 全球連續血糖監測市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
• 全球連續血糖監測市場規模、比較及成長率分析
• 全球連續血糖監測市場表現：規模與成長，2020-2025年
• 全球連續血糖監測市場預測：規模與成長，2025-2030年，2035年預測

第8章 全球總潛在市場（TAM）

第9章 市場細分

• 按組件
• 發送器、感測器、接收器
• 按年齡層
• 成人和兒童
• 按最終用途
• 醫院、居家醫療環境、診斷中心和診所及其他終端用途
• 按類型細分：發送器
• 發送器、一次性使用和可充電發送器
• 按類型細分：感測器
• 植入式感測器、經皮感測器、一次性感測器、即時感測器
• 按類型細分：接收器
• 獨立接收器、整合式接收器、穿戴式顯示設備

第10章 區域與國家分析

• 全球連續血糖監測市場：按地區、效能和預測分類，2020-2025年、2025-2030年預測、2035年預測
• 全球連續血糖監測市場：按國家、表現和預測分類，2020-2025 年、2025-2030 年預測、2035 年預測

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

• 連續血糖監測市場：競爭格局及市場佔有率（2024年）
• 連續血糖監測市場：公司估值矩陣
• 連續血糖監測市場：公司簡介
  • Roche Diabetes Care
  • Abbott Laboratories
  • Medtronic plc
  • Dexcom Inc
  • Insulet Corporation

第37章：其他領先和創新企業

• Tandem Diabetes Care Inc, Ypsomed AG, Nova Biomedical, Ascensia Diabetes Care, Bionime Corporation, Biolinq Inc, Beta Bionics Inc, AgaMatrix Inc, A Menarini Diagnostics SRL, Senseonics Holdings Inc, Medtrum Technologies Inc, Nemaura Medical Inc, LifeScan Inc, EOFlow Co Ltd, POCTech Co Ltd

第38章 全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

• 2030年連續血糖監測市場：提供新機會的國家
• 2030年連續血糖監測市場：新興細分市場機會
• 2030年連續血糖監測市場：成長策略
  • 基於市場趨勢的策略
  • 競爭對手策略

第41章附錄

Continuous glucose monitoring (CGM) is a medical technology that continuously measures glucose levels in real time throughout the day and night using a small sensor placed under the skin. It assists people with diabetes in managing their condition by providing ongoing data and alerts for high or low blood sugar levels.

The key components of continuous glucose monitoring systems include transmitters, sensors, and receivers. Transmitters are devices that send signals, such as radio waves or electrical impulses, from one point to another for communication or control. These systems are utilized by both adults and children and cater to a range of end users, including hospitals, home care environments, diagnostic centers, clinics, and other healthcare facilities.

Tariffs have influenced the continuous glucose monitoring market by increasing the cost of imported sensors, transmitters, and wearable receivers, particularly affecting advanced and real-time monitoring systems. Regions such as North America and Asia-Pacific, where significant imports occur, are most impacted. This has led to higher device costs and delayed adoption in certain markets. On the positive side, tariffs encourage local manufacturing, innovation in sensor technology, and investment in domestic supply chains, which can improve long-term market resilience and accessibility.

The continuous glucose monitoring market research report is one of a series of new reports from The Business Research Company that provides continuous glucose monitoring market statistics, including continuous glucose monitoring industry global market size, regional shares, competitors with a continuous glucose monitoring market share, detailed continuous glucose monitoring market segments, market trends and opportunities, and any further data you may need to thrive in the continuous glucose monitoring industry. This continuous glucose monitoring market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The continuous glucose monitoring market size has grown rapidly in recent years. It will grow from $9.44 billion in 2025 to $10.87 billion in 2026 at a compound annual growth rate (CAGR) of 15.1%. The growth in the historic period can be attributed to limited availability of real-time glucose monitoring devices, high cost of early cgms, growing awareness of diabetes management, dependence on finger-prick testing, increasing hospital adoption of monitoring solutions.

The continuous glucose monitoring market size is expected to see rapid growth in the next few years. It will grow to $18.86 billion in 2030 at a compound annual growth rate (CAGR) of 14.8%. The growth in the forecast period can be attributed to advancement in implantable and wearable sensors, integration with mobile health and telemedicine platforms, rising prevalence of diabetes globally, development of non-invasive glucose monitoring technology, expansion of home healthcare and remote patient monitoring services. Major trends in the forecast period include growing adoption of continuous glucose monitoring devices among diabetic patients, development of minimally invasive and implantable sensors, integration of real-time data analytics and alert systems, expansion of home-based monitoring and telehealth solutions, rising demand for pediatric and geriatric glucose monitoring solutions.

The increasing prevalence of diabetes is expected to drive the growth of the continuous glucose monitoring market in the coming years. Diabetes is a chronic condition where the body either produces insufficient insulin or cannot effectively use the insulin it produces, leading to elevated blood sugar (glucose) levels. This rise in diabetes cases is mainly due to unhealthy diets rich in sugars, fats, and processed foods, which contribute to obesity and impaired insulin function. Continuous glucose monitoring supports diabetes management by providing real-time blood sugar trends, allowing timely adjustments to diet, medication, and physical activity for better glucose control. For example, in November 2023, the American Diabetes Association, a U.S.-based non-profit organization, reported that in 2022, approximately 25.5 million people in the U.S.-about 7.6% of the population-were diagnosed with diabetes, marking a 3% increase compared to previous years. Thus, the rising prevalence of diabetes is fueling growth in the continuous glucose monitoring market.

Leading companies in the continuous glucose monitoring market are focusing on developing innovative products such as sensor-based glucose monitors to improve accuracy, real-time tracking, and patient convenience. Sensor-based glucose monitors continuously measure blood sugar levels using a small sensor inserted under the skin. For example, in August 2024, DexCom, Inc., a U.S.-based healthcare company, launched Stelo, the first over-the-counter (OTC) continuous glucose monitor (CGM) designed for adults who do not use insulin. Stelo provides real-time, 24/7 glucose readings via a small sensor worn on the back of the upper arm, sending data directly to a smartphone without the need for a prescription or fingersticks. The device offers personalized insights and trend analysis, helping users understand how factors such as diet, exercise, and sleep affect their glucose levels, enabling smarter lifestyle decisions. The sensor lasts up to 15 days, integrates with health apps, and is ideal for people with Type 2 diabetes not using insulin, those with prediabetes, or anyone monitoring their glucose health.

In September 2023, Abbott Laboratories, a U.S.-based healthcare company, acquired Bigfoot Biomedical for an undisclosed sum. Through this acquisition, Abbott seeks to strengthen its position in diabetes care by enhancing its Freestyle Libre continuous glucose monitoring technology and advancing connected solutions to make diabetes management more personalized and precise. Bigfoot Biomedical Inc., also based in the U.S., is a medical technology company that provides a diabetes management system integrating continuous glucose monitoring (CGM) technology.

Major companies operating in the continuous glucose monitoring market are Roche Diabetes Care, Abbott Laboratories, Medtronic plc, Dexcom Inc, Insulet Corporation, Tandem Diabetes Care Inc, Ypsomed AG, Nova Biomedical, Ascensia Diabetes Care, Bionime Corporation, Biolinq Inc, Beta Bionics Inc, AgaMatrix Inc, A Menarini Diagnostics SRL, Senseonics Holdings Inc, Medtrum Technologies Inc, Nemaura Medical Inc, LifeScan Inc, EOFlow Co Ltd, POCTech Co Ltd

North America was the largest region in the continuous glucose monitoring market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the continuous glucose monitoring market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the continuous glucose monitoring market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The continuous glucose monitoring market consists of revenues earned by entities by providing services such as real-time glucose tracking, remote patient monitoring, and data analytics for personalized diabetes management. The market value includes the value of related goods sold by the service provider or included within the service offering. The continuous glucose monitoring market also includes sales of Integrated insulin pumps, mobile and wearable apps and cloud-based data management platforms. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Continuous Glucose Monitoring Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses continuous glucose monitoring market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for continuous glucose monitoring ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The continuous glucose monitoring market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Component: Transmitters; Sensors; Receivers
• 2) By Age Group: Adults; Children
• 3) By End Use: Hospitals; Home Care Settings; Diagnostic Centers And Clinics; Other End Uses
• Subsegments:
• 1) By Transmitters: Reusable Transmitters; Disposable Transmitters; Rechargeable Transmitters
• 2) By Sensors: Implantable Sensors; Transcutaneous Sensors; Disposable Sensors; Real-Time Sensors
• 3) By Receivers: Standalone Receivers; Integrated Receivers; Wearable Display Devices
• Companies Mentioned: Roche Diabetes Care; Abbott Laboratories; Medtronic plc; Dexcom Inc; Insulet Corporation; Tandem Diabetes Care Inc; Ypsomed AG; Nova Biomedical; Ascensia Diabetes Care; Bionime Corporation; Biolinq Inc; Beta Bionics Inc; AgaMatrix Inc; A Menarini Diagnostics SRL; Senseonics Holdings Inc; Medtrum Technologies Inc; Nemaura Medical Inc; LifeScan Inc; EOFlow Co Ltd; POCTech Co Ltd
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Continuous Glucose Monitoring Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Continuous Glucose Monitoring Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Continuous Glucose Monitoring Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Continuous Glucose Monitoring Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.3 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.1.4 Industry 4.0 & Intelligent Manufacturing
  • 4.1.5 Artificial Intelligence & Autonomous Intelligence
• 4.2. Major Trends
  • 4.2.1 Growing Adoption Of Continuous Glucose Monitoring Devices Among Diabetic Patients
  • 4.2.2 Development Of Minimally Invasive And Implantable Sensors
  • 4.2.3 Integration Of Real-Time Data Analytics And Alert Systems
  • 4.2.4 Expansion Of Home-Based Monitoring And Telehealth Solutions
  • 4.2.5 Rising Demand For Pediatric And Geriatric Glucose Monitoring Solutions

5. Continuous Glucose Monitoring Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Home Care Patients
• 5.3 Diagnostic Centers And Clinics
• 5.4 Diabetes Management Programs
• 5.5 Research And Academic Institutions

6. Continuous Glucose Monitoring Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Continuous Glucose Monitoring Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Continuous Glucose Monitoring PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Continuous Glucose Monitoring Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Continuous Glucose Monitoring Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Continuous Glucose Monitoring Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Continuous Glucose Monitoring Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Continuous Glucose Monitoring Market Segmentation

• 9.1. Global Continuous Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Transmitters, Sensors, Receivers
• 9.2. Global Continuous Glucose Monitoring Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Adults, Children
• 9.3. Global Continuous Glucose Monitoring Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospitals, Home Care Settings, Diagnostic Centers And Clinics, Other End Uses
• 9.4. Global Continuous Glucose Monitoring Market, Sub-Segmentation Of Transmitters, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Reusable Transmitters, Disposable Transmitters, Rechargeable Transmitters
• 9.5. Global Continuous Glucose Monitoring Market, Sub-Segmentation Of Sensors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Implantable Sensors, Transcutaneous Sensors, Disposable Sensors, Real-Time Sensors
• 9.6. Global Continuous Glucose Monitoring Market, Sub-Segmentation Of Receivers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Standalone Receivers, Integrated Receivers, Wearable Display Devices

10. Continuous Glucose Monitoring Market Regional And Country Analysis

• 10.1. Global Continuous Glucose Monitoring Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Continuous Glucose Monitoring Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Continuous Glucose Monitoring Market

• 11.1. Asia-Pacific Continuous Glucose Monitoring Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Continuous Glucose Monitoring Market, Segmentation By Component, Segmentation By Age Group, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Continuous Glucose Monitoring Market

• 12.1. China Continuous Glucose Monitoring Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Continuous Glucose Monitoring Market, Segmentation By Component, Segmentation By Age Group, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Continuous Glucose Monitoring Market

• 13.1. India Continuous Glucose Monitoring Market, Segmentation By Component, Segmentation By Age Group, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Continuous Glucose Monitoring Market

• 14.1. Japan Continuous Glucose Monitoring Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Continuous Glucose Monitoring Market, Segmentation By Component, Segmentation By Age Group, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Continuous Glucose Monitoring Market

• 15.1. Australia Continuous Glucose Monitoring Market, Segmentation By Component, Segmentation By Age Group, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Continuous Glucose Monitoring Market

• 16.1. Indonesia Continuous Glucose Monitoring Market, Segmentation By Component, Segmentation By Age Group, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Continuous Glucose Monitoring Market

• 17.1. South Korea Continuous Glucose Monitoring Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Continuous Glucose Monitoring Market, Segmentation By Component, Segmentation By Age Group, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Continuous Glucose Monitoring Market

• 18.1. Taiwan Continuous Glucose Monitoring Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Continuous Glucose Monitoring Market, Segmentation By Component, Segmentation By Age Group, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Continuous Glucose Monitoring Market

• 19.1. South East Asia Continuous Glucose Monitoring Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Continuous Glucose Monitoring Market, Segmentation By Component, Segmentation By Age Group, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Continuous Glucose Monitoring Market

• 20.1. Western Europe Continuous Glucose Monitoring Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Continuous Glucose Monitoring Market, Segmentation By Component, Segmentation By Age Group, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Continuous Glucose Monitoring Market

• 21.1. UK Continuous Glucose Monitoring Market, Segmentation By Component, Segmentation By Age Group, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Continuous Glucose Monitoring Market

• 22.1. Germany Continuous Glucose Monitoring Market, Segmentation By Component, Segmentation By Age Group, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Continuous Glucose Monitoring Market

• 23.1. France Continuous Glucose Monitoring Market, Segmentation By Component, Segmentation By Age Group, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Continuous Glucose Monitoring Market

• 24.1. Italy Continuous Glucose Monitoring Market, Segmentation By Component, Segmentation By Age Group, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Continuous Glucose Monitoring Market

• 25.1. Spain Continuous Glucose Monitoring Market, Segmentation By Component, Segmentation By Age Group, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Continuous Glucose Monitoring Market

• 26.1. Eastern Europe Continuous Glucose Monitoring Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Continuous Glucose Monitoring Market, Segmentation By Component, Segmentation By Age Group, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Continuous Glucose Monitoring Market

• 27.1. Russia Continuous Glucose Monitoring Market, Segmentation By Component, Segmentation By Age Group, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Continuous Glucose Monitoring Market

• 28.1. North America Continuous Glucose Monitoring Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Continuous Glucose Monitoring Market, Segmentation By Component, Segmentation By Age Group, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Continuous Glucose Monitoring Market

• 29.1. USA Continuous Glucose Monitoring Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Continuous Glucose Monitoring Market, Segmentation By Component, Segmentation By Age Group, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Continuous Glucose Monitoring Market

• 30.1. Canada Continuous Glucose Monitoring Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Continuous Glucose Monitoring Market, Segmentation By Component, Segmentation By Age Group, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Continuous Glucose Monitoring Market

• 31.1. South America Continuous Glucose Monitoring Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Continuous Glucose Monitoring Market, Segmentation By Component, Segmentation By Age Group, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Continuous Glucose Monitoring Market

• 32.1. Brazil Continuous Glucose Monitoring Market, Segmentation By Component, Segmentation By Age Group, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Continuous Glucose Monitoring Market

• 33.1. Middle East Continuous Glucose Monitoring Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Continuous Glucose Monitoring Market, Segmentation By Component, Segmentation By Age Group, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Continuous Glucose Monitoring Market

• 34.1. Africa Continuous Glucose Monitoring Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Continuous Glucose Monitoring Market, Segmentation By Component, Segmentation By Age Group, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Continuous Glucose Monitoring Market Regulatory and Investment Landscape

36. Continuous Glucose Monitoring Market Competitive Landscape And Company Profiles

• 36.1. Continuous Glucose Monitoring Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Continuous Glucose Monitoring Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Continuous Glucose Monitoring Market Company Profiles
  • 36.3.1. Roche Diabetes Care Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Dexcom Inc Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Insulet Corporation Overview, Products and Services, Strategy and Financial Analysis

37. Continuous Glucose Monitoring Market Other Major And Innovative Companies

• Tandem Diabetes Care Inc, Ypsomed AG, Nova Biomedical, Ascensia Diabetes Care, Bionime Corporation, Biolinq Inc, Beta Bionics Inc, AgaMatrix Inc, A Menarini Diagnostics SRL, Senseonics Holdings Inc, Medtrum Technologies Inc, Nemaura Medical Inc, LifeScan Inc, EOFlow Co Ltd, POCTech Co Ltd

38. Global Continuous Glucose Monitoring Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Continuous Glucose Monitoring Market

40. Continuous Glucose Monitoring Market High Potential Countries, Segments and Strategies

• 40.1 Continuous Glucose Monitoring Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Continuous Glucose Monitoring Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Continuous Glucose Monitoring Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer